Home › Post-COVID Conditions (Long COVID) › NCT04474301
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
Well-Being and Quality of Life in Melanoma Patients During COVID-19 Pandemic
Who can join
All ages · All sexes
Full eligibility criteria
Inclusion Criteria: * Patients who have signed consent for PA15-0336 * Has an active email address and can be contacted via MyChart * Documentation of being alive per the cancer registry
About the study
The primary purpose of this study is to gain an understanding of how experiences during the COVID-19 pandemic, regardless of COVID-19 status, may have impacted multiple domains of health-related quality of life and other areas such as COVID-19 specific psychological distress, and disruptions to health care, finances and social interactions. We will also evaluate the extent to which resiliency factors such as social support, perceived benefits under times of stress, and ability to manage stress may buffer associations between COVID-19 experiences and HRQoL. To meet these objectives, we have developed a 10-minute questionnaire that taps into these areas and is based on prior work addressing concerns of other pandemics or national crises. Participants will have previously consented to protocol PA15-0336 and have provided prior lifestyle data. This will allow us to connect the COVID-19 survey data with prior existing data.
What is being tested
- Survey Administration (other)
Sponsor: M.D. Anderson Cancer Center · Participants: 1,152 · Started: Jun 11, 2020
Contact the study team
- Lorenzo Cohen · Phone: (713) 745-4260
Official record on ClinicalTrials.gov — NCT04474301
Locations in the U.S.
| Texas | M D Anderson Cancer Center, Houston |
Conditions
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.